에스케이바이오팜 - DartPoint AI, AI Insights from Disclosures

AI Insights from Disclosures

SK biopharmaceuticals Co., Ltd. 326030

Real-time prices

Company Summary

Market Sentiment

※ Click the graph to view AI analysis information for that month.

Community
News

Revenue

Operating Income

Net Income

Financials

~

Quarterly

Annual

Category

Category

Searching...

Category

Category

Category

Category

Category

Category

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Consolidated Financial Statements
Separate Financial Statements

Company Overview

as of June 2026

SK biopharmaceuticals Co., Ltd. began new drug research and development in 1993 to discover the SK Group's next-generation growth engine, and has focused on developing innovative new drugs for the central nervous system, in particular for epilepsy, targeting the vast global new drug market. The company has achieved results including the US FDA NDA approval and launch of the licensed-out sleep disorder drug solriamfetol (July 2019, product name SUNOSI(R)); the FDA NDA approval (November 2019) and US launch (May 2020, product name XCOPRI(R)) of cenobamate, its flagship epilepsy treatment; licensing-out to Europe and EC marketing authorization (March 2021) and European market launch (June 2021, product name ONTOZRY(R)); licensing-out to Japan (October 2020); licensing-out to China and Canada (December 2021); licensing-out to Israel (May 2022) and 17 countries in Latin America (July 2022); licensing-out to 16 countries in the MENA region (August 2023); and licensing-out to 30 countries including Korea (January 2024).

Representative Director Lee Donghun

Founded April 1, 2011

Corporation Type KOSPI

Industry Classification Research and experimental development on natural sciences

Corporate number 11011-4570720

Business number 101-86-62394

Phone Number 031-8093-0114

Fax Number 031-8093-0001

Website www.skbp.com

Company Address 221 Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do

Products & Services

Financial Health

Executives

Name	Position	Tenure	Birth date	Responsibilities	Sort

Employees

Shareholders

Shareholder Name	Ratio	Quantity	Sort

Industry revenue

Related Companies

Disclosures

Major Reports
Other Reports

Report	Filer	Receipt Date	Sort

Report	Filer	Receipt Date	Sort

Comments

0 / 255

AI Assistant

Change Model

Synap DU GPT Hybrid

The assistant can make mistakes. Please double-check important information.

The assistant can make mistakes. Please double-check important information.

Current Ratio, Debt Ratio, Reserve Ratio, Quick Ratio, Interest Coverage Ratio

The current ratio indicates how much larger the company's assets that can be converted to cash within one year are compared to the debts it must repay within one year.

Current Ratio = ( Current Assets / Current Liabilities ) * 100
Expressed based on 150%, the higher above 150%, the healthier.

The debt-to-equity ratio indicates the ratio of debt to total equity.

Debt Ratio = ( Total Liabilities / Total Equity ) * 100
Expressed based on 100%, the lower below 100%, the healthier.

The reserve ratio indicates how much capital the company holds excluding external borrowings.

Reserve Ratio = ( (Capital Surplus + Retained Earnings) / Capital Stock ) * 100
Expressed based on 500%, the higher above 500%, the healthier.

The quick ratio indicates the ratio of assets among current assets that can be immediately converted to cash.

Quick Ratio = ( (Current Assets - Inventories) / Current Liabilities ) * 100
Expressed based on 150%, the higher above 150%, the healthier.

The interest coverage ratio indicates the company's ability to pay interest using operating income.

Interest Coverage Ratio = ( Operating Income / Financial Expenses ) * 100
Expressed based on 250%, the higher above 250%, the healthier.

This chart visually summarizes the company's financial health using the indicators above. Using statistical data and general accounting standards, values exceeding certain thresholds are evaluated as good, and this is expressed in 5 levels.

These figures can be used as reference material, but cannot replace an accurate assessment. Therefore, there is no legal responsibility for these results, and users are advised to conduct their own investigation and analysis to make final decisions.

(Comprehensive) Income Statement, Statement of Financial Position, Statement of Cash Flows

The (comprehensive) income statement is a financial report that documents the business performance a company has achieved over a certain period. It shows profit and loss information representing business performance, or items that will affect future business performance.

The statement of financial position is a financial report that documents a company's current financial position. It shows information on assets, liabilities, and equity, where assets equal the sum of liabilities and equity. Asset and liability information is provided by current/non-current classification.

The statement of cash flows is a financial report that documents a company's cash flows occurring over a certain period. It shows the generation and use of cash by operating, investing, and financing activities.

Operating Activities: Activities related to generating primary revenue.
Investing Activities: Increases and decreases in assets held for investment purposes and property, plant and equipment used in operations.
Financing Activities: Activities related to raising and repaying funds.

For the annual settlement quarter, the (comprehensive) income statement and statement of cash flows also display the annual settlement amount (cumulative total).

Consolidated Financial Statements, Separate Financial Statements

Consolidated financial statements is a financial report prepared by combining the financial information of companies in an economic controlling-subsidiary relationship. Control is generally determined to exist when voting rights in the investee exceed 50%, and the parent company prepares the consolidated financial statements.

Separate financial statements is a financial report in which the parent company prepares financial information solely for its subsidiaries, separate from the controlling company.

Internet News Analysis

Provides the interpretation of whether the analyzed news article content is positive/negative/neutral toward the company.

Positive: The number of news articles containing positive content about the company's performance and financial information, such as stock price increases, accounting profit growth, new product/service launches and promotions/events, and MOU signings.
Negative: The number of news articles containing negative content about the company's performance and financial information, such as stock price declines, accounting profit decreases, and negative consumer reviews of products and services.
Neutral: The number of news articles containing informational content that does not directly affect corporate performance and financial information, such as mid-to-long-term planning, company name changes, and executive status.
Exposures: The sum of the number of positive, negative, and neutral news articles.

The actual number of articles and the number shown on the graph may differ depending on when the data was last updated.

Community analysis

provides the results of analyzing posts on various corporate stock pages to interpret whether the content is positive/negative/neutral toward the company.

Positive: The number of posts containing content that positively affects corporate activities, such as stock price increase outlooks, expectations of improved profitability, favorable reviews of new products or services, and agreement signings, or posts in which the author evaluates the company positively
Negative: The number of posts dealing with negative factors for the company, such as stock price declines, revenue decreases, complaints about products or services, and deteriorating management, or posts in which the author evaluates the company negatively
Neutral: The number of posts that simply convey information without clear positive or negative evaluation of the company, or that express a personal neutral opinion
Exposures: The sum of positive, negative, and neutral posts

The actual number of posts and the number shown on the graph may differ depending on when the data was last updated.

Report	Created on	PDF